首页/数据集/Intratumoural injection with iNSA/E6E7equ and iNSB/E6E7equ is well tolerated.

Intratumoural injection with iNSA/E6E7equ and iNSB/E6E7equ is well tolerated.

NIAID Data Ecosystem2026-03-13 收录

数据链接：

https://figshare.com/articles/dataset/Intratumoural_injection_with_iNSA_E6E7_sup_equ_sup_and_iNSB_E6E7_sup_equ_sup_is_well_tolerated_/17051417 数据链接链接失效反馈

官方服务：

资源简介：

Intratumoural injection with iNSA/E6E7equ and iNSB/E6E7equ is well tolerated.

应用场景：

创建时间：

2021-11-19

相关数据集

Code files for submission

癌症免疫治疗

组合疗法

Diverse combination therapies are being investigated to overcome the limitations of immune checkpoint inhibitors. However, determining the optimal combination therapy remains a challenge. Herein, we d

DataCite Commons2024-03-01 更新110

Immunotherapy in advanced NSCLC after progression on chemotherapy: real world results from a prospective institutional cohort. Supplemental Materials Data Model

癌症免疫治疗

生存分析

Parameter Estimates for Multinomial Logistic Regression. Parameter Estimates for Cox Proportional Hazards Model of Overall Survival. Parameter Estimates for Cox Proportional Hazards Model of Progre

DataCite Commons2024-05-16 更新60

Supplementary Material for: Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma

癌症免疫治疗

肝细胞癌

Introduction: Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) signaling blockade is the most effective strategy for the treatment of immune evading hepatocellula

DataCite Commons2024-03-21 更新50

Additional file 8 of Comprehensive analyses of a CD8+ T cell infiltration related gene signature with regard to the prediction of prognosis and immunotherapy response in lung squamous cell carcinoma

癌症免疫治疗

基因分析

Additional file 8: Table S4. The CIBERSORT results of LUSC patients from TCGA database.

DataCite Commons2024-08-14 更新70

Table_4_The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study.xlsx

癌症免疫治疗

耐药性突变

Cancer somatic mutations have been identified as a source of antigens that can be targeted by cancer immunotherapy. In this work, expanding on previous studies, we analyze the HLA-presentation propert

NIAID Data Ecosystem60

Intratumoural injection with iNSA/E6E7<sup>equ</sup> and iNSB/E6E7<sup>equ</sup> is well tolerated.

资源简介：

相关数据集